Together,

 we advance patient survival.

The Saudi GU (Genitourinary) Working Group is a multidisciplinary collective of healthcare professionals dedicated to improving the standards of care for genitourinary cancers — with a core focus on urothelial and prostate cancer, two of the most prevalent and challenging malignancies affecting men in Saudi Arabia.
Founded on the principles of collaboration, clinical excellence, and innovation, the GU Working Group brings together experts from across the Kingdom — including urologists, medical oncologists, radiation oncologists, pathologists, radiologists, and academic researchers — to align on national strategies, share expertise, and improve outcomes through evidence-based care.

Vision

  • A future where every patient in Saudi Arabia with urothelial or prostate cancer receives timely, personalized, and optimal care, regardless of where they live.

  • To establish a unified, data-driven, and collaborative ecosystem that transforms how urothelial and prostate cancers are detected, treated, and understood.

  • To make Saudi Arabia a regional leader in multidisciplinary, precision-based genitourinary cancer care.

  • A Kingdom where innovation, clinical excellence, and compassion meet to redefine the standard of care for prostate and urothelial cancers.

Mission

  • To unite multidisciplinary experts across Saudi Arabia in advancing the early detection, diagnosis, and personalized treatment of urothelial and prostate cancers through evidence-based practices, education, and research.

  • To elevate the standards of uro-oncology care across the Kingdom by promoting clinical excellence, collaboration, and access to the latest molecular and therapeutic innovations.

  • To empower healthcare professionals in Saudi Arabia with the tools, knowledge, and support needed to deliver world-class care for patients with urothelial and prostate cancers.

  •  To drive improvement in patient outcomes by integrating localized clinical guidelines,real- world data, and multidisciplinary collaboration into the managing  prostate and urothelial malignancies.

WHAT WE DO

We envision a future in which every healthcare provider is empowered with the knowledge and resources necessary to deliver exceptional care for patients with GU cancers. Through collaboration and ongoing education, we are providing a community of dedicated professionals committed to transforming patient lives for the better. Our offerings include engaging webinars and seminars, informative conferences, insightful podcasts, and compelling testimonials from experts in the field.

Engaging webinars

Informative Conferences

Insightful Podcasts

Compelling Testimonials

Seminars

Connecting Experts

InformativeVideos

Together, we advance patient survival